Semaglutide (known to many as Ozempic) has shown promising results in promoting weight loss by reducing appetite and caloric intake
doi: 10.1097/MPH.0b013e31815815ae Summary Keywords MNTI, clinicopathological features, BRAF , mutation, recurrence Citation Xia R-H, Zhang C-Y, Wang L-Z, Hu Y-H, Sun J-J, Tian Z and Li J (2021) Melanotic Neuroectodermal Tumor of Infancy: A Clinicopathological and BRAF V600E Mutation Study of 11 Cases
Recent articles Nutrition Weight Management For Employers Beyond weight loss: the expanding research on GLP-1s 6/25/2026 For Employers GLP-1 trends employers should know in 2026 4/21/2026 Featured Medications Weight Management New weight loss pills: what the latest FDA approvals mean 4/15/2026 Get the latest tips to your inbox
Symptoms of malnutrition include: Brittle hair, hair loss and hair pigment loss Dry, inelastic skin, rashes and lesions Frequent and severe infections Irritability, apathy or inattention Low blood pressure Low body temperature Low heart rate Serious vitamin deficiencies like Wernicke Encephalopathy Weakness, faintness and fatigue Muscle loss Wegovy users may also experience extreme muscle loss
Not everyone experiences these effects, and when they do occur they are generally short-lived
PMID 20820900